ClinicalTrials.gov
ClinicalTrials.gov Menu

To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01028755
Recruitment Status : Completed
First Posted : December 9, 2009
Last Update Posted : January 21, 2015
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2013
  Actual Study Completion Date : April 2013